Drug price history · CMS NADAC read 11 November 2026

What have pharmacies paid for Entecavir since 2013?

What pharmacies pay, not what you pay. Entecavir has 2 products in the CMS NADAC survey, 2 products with year-end prices in more than one year. NADAC is what pharmacies pay to acquire a drug, not what a patient is charged. Entecavir 0.5 MG Tablet: $30.12 per unit at the 2014 survey and $0.246 at 2026 (−99%).
Not medical or financial advice. This page reports what pharmacies pay to acquire a drug, from the CMS NADAC survey. It is not what you will be charged, and it says nothing about which medicine is right for you. Ask your pharmacist or prescriber.
Entecavir2 products in NADAC
2products with a price history
  1. Entecavir has 2 products in the CMS NADAC survey, 2 products with year-end prices in more than one year. NADAC is what pharmacies pay to acquire a drug, not what a patient is charged.
  2. Between each product's first and latest year-end survey, 1 product costs pharmacies less and none costs more, by more than 5 percent, per unit as CMS states it.
  3. 1 of the changes rest on fewer than 3 priced NDCs at one end and are marked thin: a median over one or two NDCs reflects which NDCs were priced as much as a price movement.
  4. This is a per-unit acquisition cost, not a retail price, a copay or an insurer's price, and it says nothing about why a price moved.

Entecavir 0.5 MG Tablet

Generic

$30.12 per unit at the 2014 year-end survey (3 NDCs) and $0.246 at the 2026 survey (13 NDCs): −99%.

$0$30.122014: median $30.12 per unit, 3 NDCs priced2015: median $22.40 per unit, 6 NDCs priced2016: median $13.73 per unit, 10 NDCs priced2017: median $4.38 per unit, 11 NDCs priced2018: median $1.93 per unit, 16 NDCs priced2019: median $1.38 per unit, 14 NDCs priced2020: median $1.14 per unit, 15 NDCs priced2021: median $0.844 per unit, 16 NDCs priced2022: median $0.680 per unit, 14 NDCs priced2023: median $0.556 per unit, 14 NDCs priced2024: median $0.290 per unit, 13 NDCs priced2025: median $0.221 per unit, 12 NDCs priced2026: median $0.246 per unit, 13 NDCs priced2014201620182020202220242026
year-end median across the NDCs pricedlowest to highest NDC
Year-end surveyMedian per unitLowest to highestNDCs priced
2014 (2014-12-31)$30.123
2015 (2015-12-30)$22.406
2016 (2016-12-28)$13.7310
2017 (2017-12-27)$4.3811
2018 (2018-12-26)$1.9316
2019 (2019-12-25)$1.3814
2020 (2020-12-30)$1.1415
2021 (2021-12-29)$0.84416
2022 (2022-12-28)$0.68014
2023 (2023-12-27)$0.55614
2024 (2024-12-25)$0.29013
2025 (2025-12-31)$0.22112
2026 (2026-11-11)$0.24613

Entecavir 1 MG Tablet

Generic

$30.35 per unit at the 2014 year-end survey (2 NDCs) and $0.358 at the 2026 survey (9 NDCs): −99%, a thin comparison.

$0$30.352014: median $30.35 per unit, 2 NDCs priced2015: median $23.56 per unit, 4 NDCs priced2016: median $12.62 per unit, 5 NDCs priced2017: median $4.28 per unit, 6 NDCs priced2018: median $2.21 per unit, 11 NDCs priced2019: median $1.62 per unit, 10 NDCs priced2020: median $1.30 per unit, 10 NDCs priced2021: median $0.707 per unit, 10 NDCs priced2022: median $0.743 per unit, 10 NDCs priced2023: median $0.668 per unit, 9 NDCs priced2024: median $0.438 per unit, 9 NDCs priced2025: median $0.415 per unit, 8 NDCs priced2026: median $0.358 per unit, 9 NDCs priced2014201620182020202220242026
year-end median across the NDCs pricedlowest to highest NDC
Year-end surveyMedian per unitLowest to highestNDCs priced
2014 (2014-12-31)$30.352
2015 (2015-12-30)$23.564
2016 (2016-12-28)$12.625
2017 (2017-12-27)$4.286
2018 (2018-12-26)$2.2111
2019 (2019-12-25)$1.6210
2020 (2020-12-30)$1.3010
2021 (2021-12-29)$0.70710
2022 (2022-12-28)$0.74310
2023 (2023-12-27)$0.6689
2024 (2024-12-25)$0.4389
2025 (2025-12-31)$0.4158
2026 (2026-11-11)$0.3589

CMS National Average Drug Acquisition Cost, year-end surveys 2013 to 2026. A pharmacy acquisition cost, not a retail price. About NADAC.

Where does Entecavir sit on the generic price cliff?

Entecavir 0.5 MG Tablet: the first generic approval in its Orange Book group is dated 2014. Its year-end acquisition cost in 2026 is 1% of its first observed year-end price (2014). The median matched product, 12 years after its first generic approval, is at 16% (the middle half runs from 6% to 34%), so this product is below that middle half.

0%25%50%75%100%0 years after the first generic approval: median 100%, middle half 100% to 100%, 79 products1 years after the first generic approval: median 95%, middle half 71% to 100%, 118 products2 years after the first generic approval: median 80%, middle half 49% to 99%, 135 products3 years after the first generic approval: median 64%, middle half 36% to 90%, 142 products4 years after the first generic approval: median 55%, middle half 25% to 84%, 154 products5 years after the first generic approval: median 46%, middle half 16% to 80%, 154 products6 years after the first generic approval: median 45%, middle half 16% to 87%, 154 products7 years after the first generic approval: median 40%, middle half 14% to 71%, 153 products8 years after the first generic approval: median 32%, middle half 8% to 65%, 131 products9 years after the first generic approval: median 28%, middle half 7% to 67%, 109 products10 years after the first generic approval: median 22%, middle half 5% to 53%, 90 products11 years after the first generic approval: median 21%, middle half 5% to 51%, 79 products12 years after the first generic approval: median 16%, middle half 6% to 34%, 48 products13 years after the first generic approval: median 19%, middle half 14% to 39%, 23 productsEntecavir 0.5 MG Tablet, 0 years after the first generic approval: 100% of its first observed price, 3 NDCs pricedEntecavir 0.5 MG Tablet, 1 years after the first generic approval: 74% of its first observed price, 6 NDCs pricedEntecavir 0.5 MG Tablet, 2 years after the first generic approval: 46% of its first observed price, 10 NDCs pricedEntecavir 0.5 MG Tablet, 3 years after the first generic approval: 15% of its first observed price, 11 NDCs pricedEntecavir 0.5 MG Tablet, 4 years after the first generic approval: 6% of its first observed price, 16 NDCs pricedEntecavir 0.5 MG Tablet, 5 years after the first generic approval: 5% of its first observed price, 14 NDCs pricedEntecavir 0.5 MG Tablet, 6 years after the first generic approval: 4% of its first observed price, 15 NDCs pricedEntecavir 0.5 MG Tablet, 7 years after the first generic approval: 3% of its first observed price, 16 NDCs pricedEntecavir 0.5 MG Tablet, 8 years after the first generic approval: 2% of its first observed price, 14 NDCs pricedEntecavir 0.5 MG Tablet, 9 years after the first generic approval: 2% of its first observed price, 14 NDCs pricedEntecavir 0.5 MG Tablet, 10 years after the first generic approval: 1% of its first observed price, 13 NDCs pricedEntecavir 0.5 MG Tablet, 11 years after the first generic approval: 1% of its first observed price, 12 NDCs pricedEntecavir 0.5 MG Tablet, 12 years after the first generic approval: 1% of its first observed price, 13 NDCs priced024681012years since the first generic approval
median of 200 matched productsmiddle halfeach productEntecavir 0.5 MG Tablet

This is a pattern in matched products. It does not say the first generic caused the fall, and it does not say this product's price will follow the median. See it with other drugs.

How many companies make Entecavir?

The FDA Orange Book lists 8 generic makers as marketed in its largest dosage form for Entecavir, and the first generic approval is dated 26 August 2014. The acquisition costs above are what pharmacies pay across the NDCs priced; the Orange Book count is a separate record and this page does not say that more makers lowered a price. See each maker and the patents still listed on OmniRx.

Where can you go from this record?

Open it in the check to search another drug, or see the CMS pharmacy pricing page for what NADAC measures. For who makes the generic and which patents are listed, see the generic competition check for Entecavir on OmniRx. To check whether a drug is in shortage, see the FDA drug shortages page.

Compiled and checked by Vincent Wesley Couey (ORCID 0009-0005-6869-308X) from the CMS pharmacy pricing page, year-end surveys 2013 to 2026 (latest 11 November 2026).